Skip to main content

Table 4 Mean and median percent changes when comparing the re-optimized versus the predicted dose distributions [mean change (%)/median change (%)] of the most frequently used OAR dose parameter for each of the three most frequently considered OARs per region

From: Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate

Liver

Dmax (bowel)

Dmax (duodenum)

Dmax (stomach)

 

18.2/8.5

35.6/50.8

11.2/14.0

Lung

V15Gy (lung left or right)

Dmax (heart)

Dmax (esophagus)

 

9.0/5.9

18.3/0.0

3.6/8.2

Lymph nodes

V20Gy (bowel)

V18Gy (duodenum)

Dmax (spinal canal)

 

− 10.8/− 27.8

− 43.9/− 48.2

− 2.9/− 4.4

Pancreas

V33Gy (duodenum)

V33Gy (stomach)

V33Gy (bowel)

 

− 94.8/− 97.1

− 84.0/− 99.1

− 83.4/− 98.6

Prostate

V40Gy (rectum)

V40Gy (bladder)

Dmax (femur left or right)

 

6.8/0.3

9.3/7.4

− 0.7/− 1.2